Happi Staff02.05.20
Indena, the Italian company focused on identification, development and production of high-quality active principles derived from plants, for use in the pharmaceutical, health-food and cosmetic industries, has received a grant from the Bill & Melinda Gates Foundation to work on a strategic project to improve new potential antimalarial therapies for children in disease- endemic countries.
Indena will work on a feasibility study using their proprietary technology to improve pediatric formulations of two antimalarial compounds from the portfolio of Medicines for Malaria Venture (MMV), in order to potentially improve their bioavailability. It has been challenging to develop suitable oral formulations for the two compounds in question, and it is hoped the new technology will help overcome these challenges.
Indena will work on a feasibility study using their proprietary technology to improve pediatric formulations of two antimalarial compounds from the portfolio of Medicines for Malaria Venture (MMV), in order to potentially improve their bioavailability. It has been challenging to develop suitable oral formulations for the two compounds in question, and it is hoped the new technology will help overcome these challenges.